Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

Similar articles for PubMed (Select 12685616)

1.

A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and lovastatin.

Hunninghake DB, McGovern ME, Koren M, Brazg R, Murdock D, Weiss S, Pearson T.

Clin Cardiol. 2003 Mar;26(3):112-8.

PMID:
12685616
2.

Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).

Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson AG, Crouse JR; ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation.

Am J Cardiol. 2003 Mar 15;91(6):667-72.

PMID:
12633795
3.

Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.

Insull W Jr, McGovern ME, Schrott H, Thompson P, Crouse JR, Zieve F, Corbelli J.

Arch Intern Med. 2004 May 24;164(10):1121-7.

PMID:
15159270
4.

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia.

Kashyap ML, McGovern ME, Berra K, Guyton JR, Kwiterovich PO, Harper WL, Toth PD, Favrot LK, Kerzner B, Nash SD, Bays HE, Simmons PD.

Am J Cardiol. 2002 Mar 15;89(6):672-8.

PMID:
11897208
5.

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.

Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP; Diabetes Multicenter Research Group.

Arch Intern Med. 2002 Jul 22;162(14):1568-76.

PMID:
12123399
6.

Niacin extended-release/lovastatin: combination therapy for lipid disorders.

Moon YS, Kashyap ML.

Expert Opin Pharmacother. 2002 Dec;3(12):1763-71. Review.

PMID:
12472373
7.

Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia.

Yim BT, Chong PH.

Ann Pharmacother. 2003 Jan;37(1):106-15. Review.

PMID:
12503944
8.
9.

Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.

Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, Ryan NW, Tershakovec AM.

Am J Cardiol. 2010 Feb 15;105(4):487-94. doi: 10.1016/j.amjcard.2009.10.001. Epub 2009 Nov 13.

PMID:
20152243
10.

Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study.

Rubenfire M; Impact of Medical Subspecialty on Patient Compliance to Treatment Study Group.

Am J Cardiol. 2004 Aug 1;94(3):306-11.

PMID:
15276093
11.

Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.

Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.

J Am Coll Cardiol. 2008 Apr 22;51(16):1564-72. doi: 10.1016/j.jacc.2008.03.003.

12.
13.

[Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].

Li XP, Duan J, Zhao SP, Tan MY, Xu ZM, Zhang DQ.

Zhonghua Yi Xue Za Zhi. 2006 Sep 12;86(34):2399-403. Chinese.

PMID:
17156651
14.

Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.

Lukacsko P, Walters EJ, Cullen EI, Niecestro R, Friedhoff LT.

Curr Med Res Opin. 2004 Jan;20(1):13-8.

PMID:
14741066
16.

Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.

Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K.

Indian Heart J. 2008 May-Jun;60(3):215-22.

PMID:
19240310
18.

Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.

Karas RH, Kashyap ML, Knopp RH, Keller LH, Bajorunas DR, Davidson MH.

Am J Cardiovasc Drugs. 2008;8(2):69-81.

PMID:
18422390
19.

Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia.

Capuzzi DM, Morgan JM, Carey CM, Intenzo C, Tulenko T, Kearney D, Walker K, Cressman MD.

Prev Cardiol. 2004 Fall;7(4):176-81.

PMID:
15539964
20.

Extended-release niacin for modifying the lipoprotein profile.

Guyton JR.

Expert Opin Pharmacother. 2004 Jun;5(6):1385-98. Review.

PMID:
15163282
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk